Understanding Early Multidrug Resistance in Cancer Cells
Author Information
Author(s): G.J. Schuurhuis, H.J. Broxterman, J.H.M. de Lange, H.M. Pinedo, T.H.M. van Heijningen, C.M. Kuiper, G.L. Scheffer, R.J. Scheper, C.K. van Kalken, J.P.A. Baak, J. Lankelma
Primary Institution: Netherlands Cancer Institute
Hypothesis
Is early multidrug resistance in cancer cells dependent on P-glycoprotein expression?
Conclusion
The study suggests that early multidrug resistance mechanisms can occur independently of P-glycoprotein expression.
Supporting Evidence
- Resistance to multiple drugs has been linked to P-glycoprotein, but this study shows resistance can occur without it.
- Cell lines were derived from a human lung cancer cell line and tested for drug resistance.
- Doxorubicin fluorescence was measured to assess drug distribution in resistant cells.
Takeaway
Some cancer cells can resist drugs without needing a specific protein called P-glycoprotein, which is usually thought to be responsible for this resistance.
Methodology
The study involved creating resistant cell lines from a human lung cancer cell line and measuring doxorubicin distribution using laserscan microscopy.
Limitations
The study primarily focuses on specific cell lines and may not fully represent all cancer types.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website